Case 1

Durable regression of primary cutaneous B-cell lymphomas following fever-inducing mistletoe treatment: two case reports

Orange M et al. 2012 [161]

A 51-year-old female patient and a 52-year-old male patient, both with primary cutaneous B-cell lymphoma, were in remission at the time of publication and three and a half years after the start of treatment – once only by intratumourally, subcutaneously and intravenously applied high-dose mistletoe extract and once with additional whole-body hyperthermia. 


Case 2

Complete remission and long-term survival of a patient with a diffuse large B-cell lymphoma under Viscum album extracts after resistance to R-CHOP: a case report

Gutsch et al. 2018 [160]

A 65-year-old patient with diffuse large cell B-cell lymphoma (DLBCL) stage IIa was treated with chemo-immunotherapy, which led to a slight regression of the splenic lesion. Chemo-immunotherapy was combined with additional mistletoe therapy.

Five months after the end of standard therapy, a regression of the para-aortic lymph node lesions was observed under continued subcutaneous mistletoe therapy in increasing doses. 

Under continuous mistletoe therapy, the patient is in complete remission and in good health 17 years after initial diagnosis.


Go to Heaven